This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murata, J. Articles by Azuma, I. Search for Related Content PubMed PubMed Citation Articles by Murata, J. Articles by Azuma, I.

Inhibition of Tumor-induced Angiogenesis by Sulfated Chitin Derivatives¹

Institute of Immunological Science [J. M., I. S., T. M., I. A.], Department of Polymer Science, Faculty of Science [Y. T., S. T.], Hokkaido University, Sapporo 060, Japan

The effect of antimetastatic sulfated chitin derivatives (SCM-chitin III) on angiogenesis induced by B16-BL6 cells was examined in syngeneic mice. SCM-chitin III caused a marked decrease of the number of vessels toward tumor mass (angiogenic response) without affecting the tumor cell growth when coinjected with tumor cells (on day 0), or injected into tumor site on day 1 or 3 after tumor inoculation. In contrast, carboxymethyl chitin as well as heparin had no effect. Invasion of endothelial cells through reconstituted basement membrane (Matrigel) toward tumor-conditioned media was significantly inhibited by SCM-chitin III in a Transwell chamber assay. SCM-chitin III also inhibited the haptotactic migration of endothelial cells to fibronectin-substrate, but did not inhibit the chemotactic activity in tumor conditioned media in vitro. SCM-chitin III did not directly affect the viability and the growth of tumor cells and endothelial cells in vitro. These results suggest that inhibition of lung tumor metastasis by SCM-chitin III may in part be due to the inhibition of tumor-associated angiogenesis.

¹ This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Science and Culture, for the comprehensive 10-Year Strategy for Cancer Control, from the Japanese Ministry of Health and Welfare and for Developmental Scientific Research (Grant 62870023) from the Japanese Ministry of Education, Science and Culture, as well as by Grants from the Osaka Foundation for Promotion of Clinical Immunology, the Ciba-Geigy Foundation for the Promotion of Science, and the Naito Foundation for Promotion of Science.

² To whom requests for reprints should be addressed.

Received 4/ 9/90. Accepted 10/ 1/90.

This article has been cited by other articles:

				Y.-H. Uen, Y.-J. Wang, T.-M. Hsu, M.-H. Chen, H.-Y. Chan, Y.-S. Ho, and S.-Y. Lin Effects of Fungal-derived High Molecular Weight Chitosan on 5-Fluorouracil-induced Adverse Reactions Journal of Bioactive and Compatible Polymers, September 1, 2008; 23(5): 458 - 472. [Abstract] [PDF]

				D. Chabut, A.-M. Fischer, S. Colliec-Jouault, I. Laurendeau, S. Matou, B. Le Bonniec, and D. Helley Low Molecular Weight Fucoidan and Heparin Enhance the Basic Fibroblast Growth Factor-Induced Tube Formation of Endothelial Cells through Heparan Sulfate-Dependent {alpha}6 Overexpression Mol. Pharmacol., September 1, 2003; 64(3): 696 - 702. [Abstract] [Full Text] [PDF]

				R. Folberg, M. J. C. Hendrix, and A. J. Maniotis Vasculogenic Mimicry and Tumor Angiogenesis Am. J. Pathol., February 1, 2000; 156(2): 361 - 381. [Abstract] [Full Text] [PDF]

				M. Thornton, L. Barkley, J. C. Mason, and S. Shaunak Anti-Kaposi's Sarcoma and Antiangiogenic Activities of Sulfated Dextrins Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2528 - 2533. [Abstract] [Full Text]